Search
Now showing items 1-10 of 28
Neuropsychiatric Characteristics of Alzheimer’s Disease and the Behavioral Variant of Frontotemporal Dementia
(2016)
Keywords • Alzheimer's disease • Behavioral variant of frontotemporal dementia • Early-onset dementia • Late-onset dementia • Neuropsychiatric symptoms Abstract Neurodegenerative dementias that occur in adults can present ...
First symptoms and neurocognitive correlates of behavioral variant frontotemporal dementia
(2017)
BACKGROUND: Previous works highlight the neurocognitive differences between apathetic and disinhibited clinical presentations of the behavioral variant frontotemporal dementia (bvFTD). However, little is known regarding ...
Integration of Intention and Outcome for Moral Judgment in Frontotemporal Dementia: Brain Structural Signatures
(2016)
BACKGROUND: Moral judgment has been proposed to rely on a distributed brain network. This function is impaired in behavioral variant frontotemporal dementia (bvFTD), a condition involving damage to some regions of this ...
Towards affordable biomarkers of frontotemporal dementia: A classification study via network's information sharing
(2017)
Developing effective and affordable biomarkers for dementias is critical given the difficulty to achieve early diagnosis. In this sense, electroencephalographic (EEG) methods offer promising alternatives due to their low ...
Frontal assessment battery and differential diagnosis of frontotemporal dementia and alzheimer disease
(CHICAGO, AMERICAN MEDICAL ASSOCIATION, 2004)
Comparing moral judgments of patients with frontotemporal dementia and frontal stroke
(AMERICAN MEDICAL ASSOCIATION, 2014)
Comparing moral judgments of patients with frontotemporal dementia and frontal stroke
(AMERICAN MEDICAL ASSOCIATION, 2014)
Intelligence and executive functions in frontotemporal dementia
(PERGAMON-ELSEVIER SCIENCE LTD, 2013)
Tackling variability: A multicenter study to provide a gold-standard network approach for frontotemporal dementia
(2017)
Biomarkers represent a critical research area in neurodegeneration disease as they can contribute to studying potential disease-modifying agents, fostering timely therapeutic interventions, and alleviating associated ...